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From Wartime Despair to Postwar Hope and Recovery: Japanese film
series
The Soga Japan Center is hosting two Japanese movie screenings in October that are
open to the public free of charge.
Both screenings are planned for 6 p.m. in Room 3508 Knauss Hall on WMU's main
campus.



Thursday, Oct. 22: Tomoko Fujiwara's—The Gift from Beate (2004)
Thursday, Oct. 29: Takashi Yamaguchi's—Always: Sunset on Third Street (2005)

Prof wins $416,385 NIH grant to involve
students in research
BY MARK SCHWERIN
JUNE 9, 2015 | WMU NEWS
KALAMAZOO, Mich.—A veteran Western Michigan
University psychology professor has landed a three-year,
$416,385 grant from the National Institutes of Health to
conduct research along with her students on the behavioral
pharmacology of novel stimulant drugs, commonly known
as "bath salts."
Dr. Lisa Baker, professor of psychology, will implement
animal models of substance abuse to evaluate the abuse
potential of various chemical constituents of drugs known
on the street as "bath salts." She will conduct her study with
the assistance of several undergraduate and graduate
students, who will gain valuable research experience.

RECREATIONAL DESIGNER DRUGS
Drugs known as "bath salts" have nothing in common with products on the market that are added
to bath water. They encompass a variety of recreational designer drugs that were called "bath
salts" to get around laws banning their importation and were disguised as true bath salts and were
labeled as "not for human consumption."
The drugs are synthetic cathinones derived from a plant in Africa and the Middle East whose
leaves people chewed for a boost of energy, similar to cocoa leaves, which are used to make

cocaine. They were first synthesized in the 1920s, but remained obscure until they were
rediscovered by underground chemists in the first decade of the 21st century and began to be
used in designer drugs. Legal in many jurisdictions, the drugs began to appear in Europe and
subsequently in the United States. In 2011, synthetic cathinones were classified as schedule I
substances in the United States, meaning they have no accepted medical use and they have high
abuse potential.
These designer drugs were frequently purchased from dealers on the Internet. Prior to 2011, they
were often sold in small independent stores and head shops in the United States. Bath salts have
been sold online in small packets under such brand names as "Purple Wave," "Zoom" and
"Cloud Nine."

ABOUT THE GRANT
Baker's grant is through the Academic Research Enhancement Award—AREA—program
sponsored by the NIH. The program supports research projects at educational institutions that
provide baccalaureate or advanced degrees for a significant number of the nation's research
scientists, but that have not been major recipients of NIH support, excluding big-name schools
like Harvard or Yale from applying. The awards are intended to support meritorious research,
expose students to research and strengthen the research environment of the institution.
"The AREA grant is meant to encourage faculty research," Baker says, "but, more importantly,
to engage students in that research. A major goal of Baker's project is to involve students in
research and discovery. "Students will participate in the design and implementation of
experimental methodology, data analysis, manuscript preparation and conference preparations.
Involving students in these research activities will also strengthen and enhance the University's
research environment."
Baker's project is titled "Preclinical Abuse Liability of Designer Psychostimulant Mixtures" and
will examine the effects of synthetic cathinones in combination with other commonly abused
stimulants, like cocaine, MDMA, commonly known as Ecstasy, and methamphetamine.
"People who abuse drugs are likely to engage in polysubstance abuse, using various drugs in
combination," Baker says. "We know that concurrent use of multiple stimulants poses a greater
risk for toxicities to the brain and cardiovascular system. A major aim of our research is to
determine, using animal models, if the abuse liability of psychostimulants is enhanced by
concurrent use with synthetic cathinones. For example, if someone were to consume synthetic
cathinones concurrently with the prescription stimulant, Adderall, would this person have a
greater risk of abusing these drugs?"
To address this question, Baker's laboratory will utilize three different behavioral tests with
rodents that are predictive of abuse liability.

VALUABLE RESEARCH EXPERIENCE
The outcomes of Baker's and her students' research will expand on current knowledge regarding
the behavioral and pharmacological effects of synthetic cathinones and could potentially impact
future developments in substance abuse treatment. A more immediate outcome—Baker's
students are sure to gain valuable research experience that will help them as they explore future
educational and employment opportunities.
"This type of experience will be very beneficial if they want to go to graduate school in a
neuroscience-related field," Baker says. "Graduate schools look very favorably on research
experience of student applicants. Beyond exceptional course grades and GRE test scores,
research experience during undergraduate training can be a deciding factor for admission to a
competitive graduate school."

Alumni news
Jeff Bergman '05 B.S. in mathematics recently was promoted to director of risk
management for Blue Cross and Blue Shield of Kansas. He previously served eight
years in the company’s actuarial research department as an actuarial analyst, senior
actuarial analyst and associate actuary. In his new position, Bergman is responsible for
liability insurance and risk management programs, member and group contract
administration, group underwriting, and industrial and management engineering
services. Bergman also has a master’s degree in mathematics from Kansas State
University.

